Shares of solid tumor concern Zymeworks Inc. have barely budged since the company obtained its first approval. Click here to read why ZYME stock is a Hold.

As tumor tissues express high levels of folate receptors, folate or folic acid have been widely used as a part of selective targeting of various anticancer agents, to specifically combine with folate ...

Genmab A/S (NASDAQ:GMAB), a Danish biotechnology company specializing in antibody therapeutics for cancer treatment, finds itself at a crucial juncture. With a strong portfolio of approved medicines ...

Malic acid benefits can include acne treatment, and skin care such as exfoliation and hydration. It is an alpha hydroxy acid, found naturally in fruits and wines and used as an ingredient in ...

Guava, a popular seasonal fruit in India, is packed with nutrients like fiber, antioxidants, lycopene, folate, manganese, and vitamin C. Consuming guava during winter can boost the immune system ...

The manufacturer, On Target Laboratories, said Cytalux binds to folate receptors and enters tumor cells. It glows a bright neon green during surgery. “In layman’s terms, you’re trying to ...

Study of 2.4 million participants reveals potential advantages for cardiometabolic and psychiatric conditions alongside increased risks of gastrointestinal and musculoskeletal issues Study ...

Umoja’s only clinical-stage candidate is UB-TT170, a TumorTag-based treatment that tags solid tumor cells that express folate receptor alpha. The asset is being evaluated in a phase 1 trial ...